NIH 2021 R33 HL |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) Hoffmann, Udo; Hsue, Priscilla Y.; Tawakol, Ahmed A. / University of California San Francisco |
|
NIH 2020 R33 HL |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) Hoffmann, Udo; Hsue, Priscilla Y.; Tawakol, Ahmed A. / University of California San Francisco |
|
NIH 2019 R33 HL |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) Hoffmann, Udo; Hsue, Priscilla Y.; Tawakol, Ahmed A. / University of California San Francisco |
|